SEDANA — Sedana Medical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK824.50m
- SEK751.38m
- SEK200.23m
Brief: Sedana Medical Q3 EBITDA Loss Widens To SEK 25.1 Mln
Brief: Sedana Medical's Products Receive MDR Certification
Brief: Sedana Medical Q2 EBIT Loss Widens To SEK 30 Million
Brief: Sedana Medical Q1 Operating Loss Widens To SEK 22 Mln
Brief: Sedana Medical Q4 EBITDA Loss Widens To SEK 13 Mln
Brief: Sedana Medical's Sedaconda ACD Recommended By NICE
Brief: Sedana Medical Appoints Johan Spetz As New CFO
Brief: Sedana Medical Receives IND Approval For U.S. Trials
Brief: Sedana Medical Applies For Market Approval In Italy
Brief: Sedana Medical Has Carried Out Directed Share Issue Raising Gross Proceeds Of 615 MSEK
Brief: Sedana Medical Q3 EBITDA Loss Widens To SEK 14 Mln
Brief: Sedana Medical Gets Marketing Approval In Germany
Brief: Sedana Medical Q2 EBITDA Turns To Loss Of SEK 14 Mln
Brief: Sedana Medical Receives Approval In France
Brief: Sedana Medical Says Received Positive Outcome For European Registration Application For Drug Sedaconda
Brief: Sedana Medical Announces Positive FDA Interaction
Brief: Sedana Medical Gets QMS MDR Approval
Brief: Sedana Medical Appoints Johannes Doll As New CEO
Brief: Sedana Medical Q1 Gross Profit Rises To SEK 29 Mln